Concourse Financial Group Securities, Inc. Vaxart, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding VXRT
# of Institutions
64Shares Held
9.56MCall Options Held
66.1KPut Options Held
0-
Black Rock Inc. New York, NY1.77MShares$656,5080.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$652,6360.0% of portfolio
-
State Street Corp Boston, MA851KShares$314,9140.0% of portfolio
-
Ubs Group Ag826KShares$305,5300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny597KShares$221,0530.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $46.8M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...